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Abstract
BACKGROUND: Small animal imaging has recently been the
subject of increasing interest and specific imaging devices
in particular for positron emission tomography (PET) have been
developed. To bypass limitations arising from high acquisition
costs and dependence on an in-house cyclotron unit inevitably
associated with PET, a conventional gamma camera has been
equipped with a pinhole collimator and used to visualize stri-
atal pre- and post-synaptic dopaminergic function in rats mea-
sured by the dopamine transporter ligand [123I]b-CIT and the
dopamine D2/ dopamine D3 receptor ligand [123I]IBZM. In or-
der to precisely estimate brain regions of low radioligand up-
take, single photon emission computed tomography (SPECT)
images were coregistered onto an MRI template.
MATERIAL AND METHODS: Our pinhole SPECT/MRI approach
has been employed in animal models of pre- and postsynaptic
dopaminergic dysfunction. The physical characteristics of the
scanner, the tracer kinetics and modelling as well as image
postprocessing have been addressed and associated intrinsic
problems and constraints discussed.
CONCLUSIONS: An outlook has been provided on the applica-
tion of pinhole SPECT and MRI coregistration towards non-in-
vasive investigations of drug-receptor interactions and binding
characteristics of newly developed radiopharmaceuticals.
Key words: pinhole SPECT, MRI, coregistration, dopamine
transporter, dopamine D2/D3 receptor, striatum
Introduction
Advances in image resolution and sensitivity of dedicated small
animal positron emission tomographs (PET) and single photon
emission computed tomographs (SPECT) are attracting increas-
ing interest in basic sciences [1]. Radioligands with selective bind-
ing properties and PET enable the visualization of biochemical
processes in the animals brain, give clues on the binding charac-
teristics of newly developed radiopharmaceuticals and facilitate
the characterization of disease processes in animals over time.
As a non-invasive tool, animals may be repeatedly subjected
to PET, allowing for serial study designs and consequently reducing
the number of animals needed. Apart from optical imaging ap-
proaches [2] nuclear medicine techniques are of specific interest
as they provide information of molecular processes in cells and the
functional status of tissues (molecular and functional imaging).
However, dedicated devices for small animal PET and SPECT
are associated with high investments and hence are not widely
available. In particular, PET is closely linked to an on-site cyclo-
tron enabling the supply of radionuclides in sufficient amounts.
To circumvent the lack of availability of those devices, we have
equipped a conventional single headed gamma camera with
a pinhole collimator, resulting in a three to four fold increase
in spatial resolution. In order to estimate precisely areas of low radio-
ligand uptake, SPECT images were coregistered onto MRI se-
quences obtained by a conventional whole body 1.5 Tesla scan-
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ner. Following characterization of spatial resolution, system sen-
sitivity and accuracy of SPECT-MRI coregistration the system was
challenged to characterize the striatal pre-and postsynaptic dopam-
inergic function in a living rat [3, 4]. Information of the presynaptic
dopaminergic function in the rat striatum was obtained by 2-b-
-carbomethoxy-3-b-(4-[123I]iodophenyl) tropane ([123I]b-CIT), a co-
caine derivative with high affinity for the dopamine transporter
(DAT). Postsynaptic striatal dopamine D2/D3 receptor (D2/D3R)
availability was assessed by the radioligand [123I] iodobenzamide
([123I] IBZM). We describe the properties of the system and its use
in the evaluation of animals with normal and impaired striatal
dopaminergic function. Correlations with ex-vivo markers of the
pre- and postsynaptic dopaminergic system have been performed.
This paper recounts our experiences which are more widely
applicable to small animal radiotracer imaging, and examines
some of the experimental settings where such techniques are most
likely to make a significant contribution. Finally, the future poten-
tial will be explored in the light of new technological developments.
Characterization of our SPECT system
SPECT data were acquired using a rotating single-headed
gamma camera (Siemens Orbiter ZLC 3700) equipped with a pin-
hole collimator and a 2.0 mm aperture insert. Data acquisition
was performed over a circular orbit of 360° (64 projections; 60 s/
/projection); acquisition matrix size was 128 × 128 pixels, with
16 bit depth. For [123I]IBZM pinhole SPECT acquisitions were per-
formed 81 min post-tracer injection (p.i.), and for [123I]b-CIT 320
min p.i. Studies were acquired using a 15% energy window, cen-
tred on the 159 keV photopeak of [123I]. Due to the magnification
of the pinhole collimator, a separate correction of the centre
of rotation shift was necessary. SPECT images were reconstructed
by means of filtered backprojection based on a cone-beam algo-
rithm (Nuclear Diagnostics, Sweden). As a prefilter, a Butterworth
filter was applied with an order of 5 and a cutoff frequency of 0.4 cy-
cles cm-1. No corrections for attenuation and scatter were per-
formed. Anatomical information of the rat brain was obtained with
the help of a modified whole body 1.5-T MRI scanner (Siemens)
equipped with a flex loop. The MRI protocol included a T2-weight-
ed spine echo sequence (TR, 3000 ms; TE, 96 ms; matrix 256 ×
× 256 pixels, slice thickness 2 mm; field of view (FoV) 65 mm;
acquisition time ~13 min). In order to precisely define regions
of interest (ROIs) on the SPECT images, the individual SPECT data
set was transferred on a previously computed MRI template, av-
eraging three individual MRIs of normal rats. The fully automated
registration approach is based on the maximization of mutual in-
formation [5] and implemented into SPM 99 (Statistical Paramet-
ric Mapping, Wellcome Dept. Cogn. Neurol., London) [6]. ROIs
were then drawn on related anatomical structures visualized
on the MRI template and transposed to the corresponding SPECT
slice using the MRIcro software (version 1.37, Chris Rorden, Not-
tingham, UK).
System sensitivity, spatial resolution, and SPECT-MRI coreg-
istration measurements were obtained using different phantoms
at a radius of 45mm from the pinhole collimator aperture to the
axis of the collimator rotation. Studies of the dependence of sys-
tem resolution on the radius of rotation have been reported
by Weber and colleagues [7]. System sensitivity was 0.081 cps/kBq
for a 2.0 mm aperture pinhole collimator. The measured recon-
structed axial and transaxial in-plane resolution calculated
as full width at half maximum (FWHM) was 3.5 mm including the
effects of applied filters. The average misregistration between
MRI and SPECT images as measured by the distance between
external markers on both image modalities was 1.2 mm in the
transaxial plane and 1.1 mm in the axial plane.
Pinhole SPECT imaging of striatal
dopaminergic function in the rat
Prior to assess radiotracer uptake in animals with dopaminer-
gic dysfunction the optimal injection dose and acquisition period
have to be determined in healthy animals. Male Wistar rats with
narrow weights ranging from 290g to 310g were scanned serially
over seven hours at different tracer dosages. Washout rates (%/h)
of the striatum and cerebellum have been calculated and the data
fitted to a model accordingly (please see section: Tracer kinetics
and modelling). Once the optimal tracer dose and acquisition
period was determined, striatal [123I]b-CIT and [123I]IBZM binding
was assessed in animal models of pre- and postsynaptic dopa-
minergic dysfunction. To mimic the decrease of DAT availability,
which is related to the loss of dopaminergic neurons, the well-
established and frequently cited 6-hydroxydopamine (6-OHDA)
model of Parkinsons disease (PD) was used [8]. 6-OHDA, a syn-
thetic neurotoxin has been reported by Ungerstedt to selectively
destroy dopaminergic neurons projecting from the substantia ni-
gra to the striatum when injected into the medial forebrain bundle
of the rat [9]. Five animals received 8 µl 6-OHDA (2 µg/µl) into the
left medial forebrain bundle [10]. The striatal [123I]b-CIT uptake has
been correlated to surviving dopaminergic neurons in the sub-
stantia nigra visualized by tyrosinhydroxylase immunohistochem-
istry. Linear regression analysis showed that the measurements
of striatal [123I]b-CIT uptake and nigral tyrosinhydroxylase positive
cell counts were highly correlated, confirming the sensitivity
of [123I]b-CIT pinhole SPECT for assessing dopaminergic deficits
in lesioned animals. This is in line with a small animal pinhole
SPECT study in unilaterally dopamine depleted mice showing tight
correlations of striatal DAT binding and ex vivo DAT immunohis-
tochemistry [11].
Analogous to 6-OHDA lesioning of the medial forebrain bun-
dle, postsynaptic decline of striatal D2/D3R expression was
achieved by administering the N-methyl-D-aspartate receptor
agonist quinolinic acid (QA) stereotactically into the striatum, well-
known as a rat model of Huntingtons disease [12]. QA induces
selective neuronal degeneration of D2/D3R baring medium-sized
spiny neurons, which are known to express the dopamine and
cyclic adenosine 35-monophosphate-regulated phosphorus-pro-
tein (DARPP-32) in high concentrations. DARPP-32 positive neu-
rons can be visualized by immunohistochemistry. In our model
high correlations between striatal IBZM uptake values and both
volume and optical density measures of remaining striatum were
found in animals of increasing striatal D2/D3R damage. Correla-
tions between striatal lesions and motor tasks performed in those
animals were weaker when compared to striatal IBZM uptake,
suggesting in particular in animals with small striatal lesions that
IBZM pinhole SPECT is more sensitive in the detection of mild
striatal dopaminergic dysfunction.
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Practical issues in pinhole SPECT
imaging of small animals
Animal positioning and injection of the radioligand
Imaging artefacts caused by head movements or motion
caused by breathing must be kept to a minimum as those will
lead to a positional shift severely affecting SPECT-MRI coregistra-
tion. To keep animals motionless the use of anaesthetics is strongly
suggested. The choice of anaesthetic agent relies on its binding
characteristics to neuroreceptors and must not interfere with the
radiotracer administered [13]. At our department isoflurane ana-
esthesia is used routinely as this is not reported to interact with
the dopaminergic system. In case of new radioligands, cross val-
idation with other anaesthetics are recommended using ex-vivo
methods for receptor quantification. Once the rat is anaesthetized
a femoral vein can be easily canulated for bolus injection or contin-
uous infusion of the radioligand and then placed to the tomograph.
To guarantee accurate positioning of the animal in the FoV and
to facilitate SPECT-MRI coregistration the rats head has been held
in a Perspex stereotaxic frame (based on the commercial Kopf small-
-animal stereotaxic frame), which keeps artefacts caused by gam-
ma ray and nuclear magnetic resonance to a minimum.
Small animal gamma cameras
Recently a number of dedicated devices for small animal
SPECT imaging have been described. Del Guerra et al reported
on an integrated PET-SPECT system based on four detector heads
with 4 × 4 × 4cm YAlO3: Ce crystals [14]. In this system a compa-
rable resolution with slightly higher sensitivity is achieved (3.1 mm
FWHM and 0.031cps/kBq).
Another system is based on the use of multiple pinhole SPECT
and conventional gamma camera technologies. By applying
a dedicated iterative reconstruction software, high resolution im-
ages can be acquired. By using such a device, termed Nano-
SPECT (Bioscan, Washington DC, USA) a spatial resolution be-
low 1 mm FWHM and sensitivity of 1cps/kBq can be achieved.
Similarly high resolution has been reported from another system
based a slit-parallel rake collimation (Linoview Systems BV, Am-
sterdam, the Netherlands). Although these systems now offer
imaging studies even in mice with high restrict sensitivity, consid-
erable acquisition costs restricts its application to dedicated im-
aging research centres.
Specification of radioligands
[123I]IBZM was obtained from Amersham Health B.V. (Eind-
hoven, the Netherlands) with a radiochemical purity of 95% and
a specific activity > 74 GBq/µmol. [123I]b-CIT has been delivered
from the Arsenal Research (Seibersdorf, Austria) with a radiochem-
ical purity >95% and specific activity > 55 GBq/µmol. The count
statistics per voxel in the striatum at equilibrium conditions was
highest in animals receiving 37MBq ([123I]b-CIT) and 44.4MBq
([123I]IBZM) and comparable to voxel values in humans. Our data
support previous reports, indicating that high resolution imaging
of small animals cannot be performed with tracer doses scaled
down to ratios of animal to human body masses [15, 16].
The reason for this is that the size of the resolution voxel appropri-
ate to the rat scales with the mass to the animal. A rat is about 230 times
smaller in mass and size compared to a human. The volume
of a voxel in our animal study is 1 mm3 whereas in a human SPECT
acquisition it is about 64 mm3. To gain the same statistical preci-
sion of measured activity in the voxels of a rat, at least a quarter
to one-third of the radioactivity administered to a human must
then be delivered to the small animal voxels assuming compara-
ble system sensitivities of the human and small animal SPECT
study. However, injections of nearly equivalent amounts of radio-
ligand as compared to humans might elicit a pharmacological
response and in addition violate the assumptions underlying trac-
er kinetic models. It is generally believed that a receptor occupancy
of 5% represents the threshold at which the dose can no longer
be considered as a tracer quantity and may elicit a pharmacolog-
ical response. Based on receptor occupancy studies for raclo-
pride, a D2/D3 agonist with comparable receptor affinity, the max-
imum injectable dose of 74 MBq was calculated for [123I]IBZM,
respectively. Considering tolerable bolus injection maxima in rats
of 0.51 ml without endangering the animals blood circulation,
we set the maximum of our bolus injection volume to 0.7 ml and
this resulted in activities of 44.4 MBq and 37 MBq for [123I]IBZM
and [123I]b-CIT, respectively. Generally the evaluation of potential
mass effects in small animal imaging is crucial, especially when
studying low capacity targets such as receptors [17].
Tracer kinetics and modelling
In order to derive adequate measures tracer kinetics have been
assessed for [123I]b-CIT and [123I]IBZM by serial scans. True tracer
equilibrium conditions requiring tracer washout rates below 5%/h
were identified for [123I]b-CIT from 285-355min p.i. As a conse-
quence the equilibrium model for [123I]b-CIT reported by Laruelle
and colleagues was applied to our datasets since it does not re-
quire multiple scans or the measurement of arterial plasma tracer
concentration [18]. The outcome measure, which is termed spe-
cific-to-nondisplaceable equilibrium partition coefficient (V3),
is proportional to the ratio of receptor density (Bmax). The equilibrium
model relies on several assumptions: first, the stability of regional
tracer uptake during image acquisition, and second, the negligi-
ble DAT receptor density in the cerebellum representing the non-
-specific bound and free activity.
Serial scans following a bolus of [123I]IBZM identified washout
rates of more than 5%/h in the striatum and cerebellum; however,
the slopes of tracer uptake in the striatum and cerebellum were
identical from 81355 min p.i. indicating a secular equilibrium,
which is known to be a constant linear function of ratios obtained
at true equilibrium again providing an index of Bmax [19].
Magnetic resonance imaging coregistration
and ROI analysis
Since D2/D3R and DAT-SPECT does not provide anatomical
details of brain areas with nonspecific radioligand uptake such
as the cerebellum or occipital cortex and of specific tracer uptake
such as the dopamine and D2/D3R-depleted striatum from sur-
rounding areas, anatomical information of those ROIs is needed.
To guarantee fully automated processing of imaging data rang-
ing from data acquisition to the calculation of regional count sta-
tistics, an image coregistration approach based on mutual infor-
mation, a basic concept from information theory, described
by Collignon and co-workers, was successfully introduced for SPECT-
-MRI coregistration in our studies [5]. Brain templates consisting
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of healthy rats were built for [123I]IBZM/[123I]b-CIT SPECT and
T2 weighted MRI. Consecutively, SPECT templates have been
coregistered onto the MRI template. Since the decline of count
statistics and associated structural resolution in lesioned animals
limited the application of aligning the SPECT image directly onto the
MRI, the individual SPECT image was matched to the correspond-
ing SPECT template previously coregistered onto the MRI tem-
plate. Finally, ROIs have been delineated on the MRI template
and transposed onto the individual SPECT image (Figure 1).
Applications of pinhole SPECT imaging
Characterization of animal models based
on neuroreceptor dysfunction
The in-vivo assessment of animal models of Parkinsons dis-
ease and Huntingtons disease primarily relnies on behavioural
tests sensitive to striatal dopaminergic dysfunction [2022]. Be-
havioural tests, although economic and simple, often fail to accu-
rately reflect mild to moderate degrees of striatal dopaminergic
dysfunction [23]. In contrast small animal PET and 18F-DOPA and
[11C] raclopride enable direct insights into the striatal dopaminergic
system [24]. The feasibility to visualize striatal DAT and D2/D3R
distributions in rats and mice and its correlation with behavioural
parameters has also been reported for small animal pinhole SPECT
[3, 4, 7, 25, 26]. It has to be pointed out that improvement
of spatial resolution by pinhole collimators is achieved at the expense
of reduced counts per voxel. Lower system sensitivity, however
is compensated in part by the utilization of tracers labelled with
longer half-life isotopes as [123I] and [99mTc], characterized by very
high specific activities, which are at least equivalent or higher than
those achieved with conventional PET radionuclides. Typical exam-
ples of pinhole SPECT in normal and unilaterally lesioned rats using
both 123I-IBZM as well as 123I-b-CIT are shown in Figure 1. Coregis-
tration with MRI allows anatomical localisation and ex vivo immuno-
histochemistry shows good correlation with tracer uptake in lesioned
animals. The gamma camera setup is shown in Figure 2.
When reviewing the literature, the characterization of the stri-
atal dopaminergic system in small animals with PET and SPECT
has attracted the most attention of researchers. To a minor extent
reports on the application of [99mTc]-HMPAO to visualize blood
perfusion of small brain structures or brain tumours are available
[7, 27]. Ohmori and colleagues investigated the lipid metabolism
in a middle cerebral artery occlusion model with pinhole SPECT
using an [123I]labelled diacylglycerol [28]. Pinhole SPECT was also
shown to be useful in visualizing with [123I] iomazenil the distribu-
tion of GABA-A receptors in the brains of rats [27]. The use
Figure 1. Selected examples of pinhole SPECT using a conventional gamma camera system (Siemens Orbiter). A. Coronal sections of striatal uptake
of 123I-b-CIT in a normal rat; B. Unilaterally 6-OHDA lesioned rat; D. The corresponding MR slice; E. [123]b-CIT SPECT image coregistered onto the corre-
sponding MRI slice; G. The ex vivo immunohistochemical staining of dopaminergic neurons in the substantia nigra; C. [123I]IBZM pinhole SPECT of the
striatum of a unilaterally QA lesioned rat, again coregistered onto the corresponding MRI slice (F); H. Ex vivo DARPP-32 immunohistochemistry of striatal
neurons in the same animal.
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of pinhole SPECT for the characterization of animal models of ce-
rebral diseases is still in its infancy and further studies with radio-
ligands evaluating cerebral blood perfusion and metabolism in ro-
dents are needed to extend its application to numerous animal
models in the fields of cerebro-vascular and neurodegenerative
diseases as well as epilepsy.
Characterization of radioligands
Animal SPECT is increasingly applied towards evaluation
of new radiopharmaceuticals. The advantage over classical dis-
section and gamma counting lies in the fact that the number of ani-
mals necessary can be reduced and pharmacokinetic behaviour
such as excretion patterns, organ uptake and tissue retention over
time can be visualized. This becomes increasingly important
in the development of radiotracers for brain imaging [29], but also
for other applications such as oncology [30, 31]. Some challeng-
es may be addressed by using SPECT, for others (e.g., excretion
patterns) dynamic planar imaging might be sufficient.
Characterization of drug-receptor
interactions
Another interesting approach might be to study receptor oc-
cupancy by novel drugs, evaluated with specifically designed ra-
diotracers with high affinity and selectivity for these target binding
sites. Occupancy of D2Rs in the mouse striatum has been mea-
sured for cold raclopride with the SPECT tracer [123I] IBF under
tracer-to-receptor equilibrium conditions using constant infusion
techniques [32]. This setting allows the kinetics of drugs acting
on the same receptor to be modelled.
Of course, a special advantage is the option of subsequent
imaging of the same animal e.g. before and after drug treatment,
giving better insight into regulatory effects potentially caused
by the compound to be tested on the neuroreceptor expression.
Those studies are of particular interest when pursuing the discus-
sion on potential long term effects of initial dopamine agonist ad-
ministration versus levodopa in early PD. A 46-month follow
up assessment revealed a significant one-third reduction in rela-
tive rates of decline of striatal [123I]b-CIT uptake in the dopamine
agonist arm compared with the levodopa arm [33]. The possibil-
ity that dopamine agonists and levodopa itself might exert regula-
tory influences to various degrees on the number of DAT ex-
pressed, the radiotracer affinity and receptor occupancy led to
major difficulties in the interpretation of the clinical relevance of
such findings [34, 35] and suggests that this issue needs to be
addressed prior to the application of DAT SPECT as a biomarker
for the effects of dopaminergic treatment on the nigrostriatal
dopaminergic system.
Conclusion
The system described herein allows the use of a conventional
SPECT system, available in every nuclear medicine department,
to be used for high resolution imaging of small animals. Potential
fields of application of pinhole SPECT and MRI coregistration are
seen in the characterization of animal models, the non-invasive
and repetitive investigations of drug-receptor interactions and
evaluation of biodistribution and binding characteristics of newly
developed radiopharmaceuticals.
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